Related Experiment Video
Updated: Jun 23, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Functional studies of rat galactokinase
Xiusheng Chu1, Nan Li, Xiaojun Liu
1Department of Biology and Chemistry, City University of Hong Kong, Hong Kong SAR, China.
Journal of Biotechnology
|May 13, 2009
Summary
Understanding galactokinase enzyme function is key for galactosemia therapies. This study reveals ATP binding induces conformational changes for galactose binding and identifies Asp186 as a potential catalytic residue.
Area of Science:
- Biochemistry
- Enzymology
Background:
- Galactokinase (GALK) is an ATP-dependent enzyme crucial for galactose metabolism.
- Defects in human GALK cause galactosemia, while inhibition is a therapeutic target for classic galactosemia.
- Understanding GALK-substrate interactions is vital for drug development and carbohydrate-based natural product synthesis.
Purpose of the Study:
- To elucidate the substrate-binding mechanism of rat galactokinase.
- To identify key residues involved in catalysis and ATP binding.
- To explore potential inhibitors of galactokinase activity.
Main Methods:
- Cloning and purification of N- and C-terminal His-tagged rat galactokinase.
- Construction and purification of variant galactokinase enzymes.
- Enzymatic kinetics studies using galactose and analogs as substrates.
- Characterization of ATP binding sites using fluorescent trinitrophenyl-ATP.
Main Results:
- ATP binding appears to induce a conformational change in galactokinase, facilitating specific galactose binding.
- Aspartate at position 186 (Asp186) is identified as a potential catalytic residue.
- Aminoglycosides and flavonoids were found to be competitive inhibitors of rat galactokinase.
Conclusions:
- The study provides insights into the catalytic mechanism and substrate specificity of galactokinase.
- Identification of Asp186 and potential inhibitors offers avenues for therapeutic strategies against galactosemia.
- Understanding enzyme kinetics and binding interactions is crucial for developing novel carbohydrate-based therapeutics.
